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ABSTRACT 
Division and cell proliferation is an essence of life. A human cell has in its core a very 
simple yet a very complex machinery to coordinate cell cycle activities and events. A 
somatic human cell has as a base four different cell cycle stages: a preparatory cell 
growth stage (G1) a synthetic stage where genomic material is replicated (S) a second 
growth and preparation stage (G2) and a mitotic stage, where genetic material is 
segregated in two new cells (M). The main driver of these phase shifts is the oscillatory 
behavior of cell cycle proteins called Cyclins, which are being produced and degraded in 
a periodic manner. Cyclins steer kinase activity, and function together with other cell-
cycle kinases as Polo-like kinase 1 (Plk1). On top of the cell cycle regulation a cell has 
important mechanisms to sense and repair DNA damage, a so-called DNA damage 
response. DNA damage occurs regularly because of intrinsic factors related to cellular 
activities e.g. genome replication, metabolism or exogenous factors like solar radiation. 
Therefore, the response to DNA damage is an inherent part of the cell cycle and its main 
action is to halt cell cycle progression and establish a checkpoint. A cell has several 
checkpoints throughout the cell cycle: a G1/S checkpoint, an intra-S checkpoint, a G2/M 
checkpoint and a M-checkpoint. At these positions a cell can stop or slow down in case 
of unfavorable conditions, stress or DNA damage. To take care of DNA damage, repair 
mechanisms are put in place and if possible, a cell eventually continues proliferation 
(checkpoint recovery) or exits the cell cycle. 
In this thesis I focused on the regulation that precedes mitotic entry – the regulation of 
G2 phase during both normal mitotic entry and after checkpoint activation. I further 
focused on the activity of the protein Plk1 that is important but not essential to enter 
mitosis in a normal cell cycle, but becomes indispensable for mitotic entry after DNA 
damage.  
For this study I employed a biosensor for Plk1 activity, Plk1-FRET, and developed a 
setup that allows to follow single cells expressing the sensor over several cell cycles and 
later quantify the signals. To study protein behaviors we further developed a technique 
that allows to elucidate dynamics of the cell cycle proteins from fixed cells growing on 
micropatterns. Using this approach combined with endogenously tagged Cyclin A and 
Cyclin B cell lines and a Plk1-FRET biosensor, we find that activities that precede mitotic 
entry are in place several hours before mitosis, at the completion of S phase, contrary to 
the previous belief that the mitotic entry network is activated less than an hour before 
mitosis. We further employed two different model systems and find that Cdk1 and 
Plk1/Plx1 coordinate degradation of Bora, a protein important for Plk1 activation. We 
find that in human cells Plk1-induced Bora degradation starts about two hours before 
mitosis, at the time when Plk1 activity reaches the cytoplasm. Moreover, a small pool of 
Bora is not degraded and is stabilized in mitosis, providing the possibility to keep Plk1 
active in mitosis. 
Lastly, using a micropatterning approach and Plk1-FRET biosensor in combination with 
a probe for APC/C activation I show that upon checkpoint activation in G2 there is a 
decision point marked by a threshold of Plk1 activity. Activity above this threshold 
correlates with progression to mitosis, whereas activity below it correlates with cell 
cycle exit. Furthermore, cells damaged in S phase can exit the cell cycle in two positions 
in G2, with and without upregulating Plk1 activity, indicating that Plk1 activity is not 
required for cell cycle exit. Likewise, G1 cells that crossed the G1/S border after 
receiving DNA damage can exit the cell cycle in G2 phase, in a similar manner as cells 
receiving DNA damage in S-phase. 
Taken together our results shed light on the activities underlying the G2/M transition 
both in an unperturbed cell cycle and after DNA damage. 
  
  
LIST OF SCIENTIFIC PAPERS 
 
I. Hukasova E, Silva Cascales H, Kumar SR, Lindqvist A. Monitoring 
Kinase and Phosphatase Activities Through the Cell Cycle by 
Ratiometric FRET. J. Vis. Exp. 1–6 (2012) 
II. Akopyan K*, Silva Cascales H*, Hukasova E*, Saurin AT, Müllers E, 
Jaiswal H, Hollman DA, Kops GJ, Medema RH, Lindqvist A. Assessing 
kinetics from fixed cells reveals activation of the mitotic entry network 
at the S/G2 transition. Mol. Cell 53, 843–853 (2014). 
III. Feine O, Hukasova E, Bruinsma W, Freire R, Fainsod A, Gannon J, 
Mahbubani HM, Lindqvist A, Brandeis M. Phosphorylation-mediated 
stabilization of bora in mitosis coordinates Plx1/Plk1 and Cdk1 
oscillations. Cell Cycle 13, 1727–1736 (2014). 
IV. Hukasova E, Lindqvsit A. Cell cycle exit after DNA damage can occur at 
two positions in G2 phase. Manuscript 
 
 
* Equal contribution 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ADDITIONAL PAPERS 
Mäki-Jouppila JH, Laine LJ, Rehnberg J, Narvi E, Tiikkainen P, Hukasova 
E, Halonen P, Lindqvist A, Kallio L, Poso A, Kallio MJ. Centmitor-1, a novel 
acridinyl-acetohydrazide, possesses similar molecular interaction field and 
antimitotic cellular phenotype as rigosertib, on 01910.Na. Mol Cancer Ther. 
2014 May;13(5):1054-66 
 
I.. 
 
CONTENTS 
1 INTRODUCTION ....................................................................................................................... 1 
1.1 THE CELL CYCLE ......................................................................................................... 1 
1.1.1 REGULATORS OF THE CELL CYCLE ......................................................... 2 
1.1.2 REGULATION OF THE MITOTIC ENTRY ................................................... 3 
1.1.3 POLO-LIKE KINASE FAMILY: STRUCTURE AND FUNCTIONS ........... 4 
1.1.4 AURORA BOREALIS (BORA) ........................................................................ 6 
1.2 DNA DAMAGE RESPONSE ......................................................................................... 8 
1.2.1 REPAIR OF DSBs ............................................................................................... 9 
1.2.2 CHECKPOINT CONTROL: CELL CYCLE CHECKPOINTS ....................... 9 
1.2.3 CHECKPOINT RECOVERY COMPETENCE .............................................. 10 
1.2.4 APC/C-Cdh1 ACTIVATION UPON DNA DAMAGE .................................. 12 
1.2.5 PLK1 ACTIVATION AFTER DNA DAMAGE ............................................ 12 
1.2.6 PLK1 AS A TARGET OF DNA DAMAGE SIGNALING ............................ 12 
1.3 PLK1 AND CANCER.................................................................................................... 14 
1.4 METHODS ..................................................................................................................... 15 
1.4.1 FRET-BASED BIOSENSORS ......................................................................... 15 
1.4.2 FLUORESCENCE LIVE CELL IMAGING ................................................... 16 
1.5 GENERAL DISCUSSION ............................................................................................. 18 
1.5.1 PLK1 IMPORTANCE FOR MITOTIC ENTRY ............................................ 18 
1.5.2 WHERE IS PLK1 ACTIVATED? ................................................................... 18 
2 AIMS ......................................................................................................................................... 21 
3 RESULTS AND DISCUSSION ............................................................................................... 23 
3.1 Monitoring Kinase and Phosphatase Activities Through the Cell Cycle by 
Ratiometric FRET (Paper I) ........................................................................................... 23 
3.2 Assessing Kinetics from Fixed Cells Reveals Activation of the Mitotic Entry 
Network at the S/G2 Transition (Paper II) ..................................................................... 24 
3.3 Phosphorylation-mediated stabilization of Bora in mitosis coordinates Plx1/Plk1 
and Cdk1 oscillations (Paper III).................................................................................... 25 
3.4 Cell cycle exit after DNA damage can occur at two positions in G2 phase (Paper 
IV) ................................................................................................................................... 26 
4 FUTURE OUTLOOK ............................................................................................................... 27 
5 ACKNOWLEDGEMENTS ...................................................................................................... 29 
6 REFERENCES .......................................................................................................................... 33 
 
 
  
  
LIST OF ABBREVIATIONS 
Plk1 
Cdk 
Polo-like kinase 1 
Cyclin-dependent kinase 
DDR  DNA damage response 
PBD 
FRET 
Polo-box domain  
Förster resonance energy transfer 
Plk1-FRET FRET-based reporter for kinase activity of Polo-like kinase 1 
DSB 
ssDNA 
Checkpoint recovery 
Checkpoint control 
 
 
Double strand break 
Single stranded DNA 
A re-entry into the cell cycle after genotoxic stress 
A system of checkpoints to sense DNA damage or 
unfavourable conditions during cell cycle progression 
 
 
 
 
 
 
 
 
 
  1 
1 INTRODUCTION 
1.1 THE CELL CYCLE 
Cell cycle as we define it today is an order of events that lead to cell division. These 
events include cell growth, replication of genetic material and organelles, segregation of 
genetic material and organelles and separation of two daughter cells1. Dependent on the 
context of cell cycle it can occur in a “fast mode” and alternate only between replication 
and division cycles like in early embryonic cycles of fertilized egg1,2. Here a cell is of a 
big size at start and has all the nutrients to skip growth phases and focus on cell 
division, resulting in many small daughter cells from one big mother cell. In somatic 
cells, however, cells are of a standard size at the start of each cycle and therefore need 
time to grow and accumulate proteins to enter replication and division, thus event 
occur in a “slow mode”1,2.  
Every event in the cell cycle constitutes a corresponding phase: G1, S, G2 and M. G1-
preparation for division, S-replication of chromosomes, G2-preparation for mitosis, M-
mitosis, segregation and separation of chromosomes to two daughter cells (Figure1)1. 
In early days G-phase was standing for Gap phase, periods where visually nothing 
happened, and a cell rested from active division. Later G-phases were renamed Growth 
phases, as we learned that cells use this time for growth. However, what exactly 
happens in G-phases is not very obvious. Why coming from embryonic cycles, a cell 
evolves such long gap phases? Somatic cells can remain in G1 stage for a half of the cell 
cycle time in favorable conditions1. In stress conditions this time is even longer, and 
some cells remain outside active division for a long time, entering so-called G0.1 
G1 phase is finished once a cell initiates replication of its genetic material. In case of G2 
phase the definition is more vague, as it is defined as a time between completion of DNA 
synthesis and initiation of mitosis. For a long time this stage has been overlooked and 
its importance emerged at the event of genotoxic stress. G1 and G2 stages are places 
where cells arrest after damage occurs to the genetic material3. Besides, for many 
transformed cells G2 is the only possible stop point before mitosis4,5. In epithelial cells 
G2 phase is estimated to last approximately 4-6 hours. So why is G2 phase necessary, 
when does it start and why does it take so long? The author hopes that her work 
presented in this thesis contributed to a better understanding of the regulation and 
importance of G2 phase in a somatic cell. 
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Figure 1: A schematic of the cell cycle progression (from nobelprize.org) 
 
1.1.1 REGULATORS OF THE CELL CYCLE 
Since cell proliferation is an essence and a definition of life, it must be regulated by a 
fundamental and well-conserved mechanism. In fact, it is. In 2001 a Nobel prize was 
awarded for the discovery of key regulators of the cell cycle in three different species: a 
bakers yeast Saccharomyces cerevisiae, a fission yeast Schizosaccharomyces pombe and a 
sea urchin Arbacia6. Together these discoveries brought to the identification of a protein 
Cyclin and a Cyclin dependent kinase (Cdk) as main regulators of the cell cycle. Today 
we identify several Cyclin-Cdk complexes as regulators of distinct stages of the cell 
cycle. Moreover, over a dozen of cyclins and Cdks were identified over the years7.  
In mammalian cells at least two Cyclins are present in G2 phase: Cyclin A2, its 
expression is induced at the start of S phase and Cyclin B1, production of which is 
induced in G2 preceding mitotic entry. At the same time there are two Cdks that can 
form complexes with either of the cyclins: Cdk2, essential for S phase progression as 
Cdk2-Cyclin A complex and Cdk1, essential for triggering mitosis as Cdk1-Cyclin B 
complex. Although in some organisms Cdk-Cyclin A is essential to promote mitosis8, its 
importance in human cells is still debated. 
A key feature of the cell cycle regulation is that it needs to occur in a periodic manner. 
One cycle has to end for another one to start. One phase needs to precede the other and 
progression has to be unidirectional. This is achieved by cycles of production and 
degradation of Cyclins, creating an oscillator of Cdk activity – a cell cycle oscillator9. 
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This mechanism puts timely protein degradation on important place in regulation of cell 
cycle exit and re-start of the cell cycle. It is achieved through the function of anaphase-
promoting complex/cyclosome (APC/C), an E3 ubiquitin ligase that is activated and 
targeted to its substrates by the specific subunits Cdc20 and Cdh1 and by SCF 
(Skp1/cullin/F-box protein)-related complexes10. In early Xenopus embryos the system 
works as a simple oscillator: Cyclin-Cdks at the peak of their activity phosphorylate and 
activate APC, which after short delay degrades cyclins and resets the system11. Thus, 
Cdks regulate their own degradation. 
However, in somatic cells introduction of a G1-phase and a presence of several Cyclin-
Cdks require additional level of regulation. Here mitotic Cdk activation has to be 
prevented during G1 phase, therefore APC/C regulated by the Cdh1 subunit is active 
from the end of mitosis and throughout G111. Additionally, APC/C-Cdc20 degrades 
distinct Cyclins at defined times during mitosis12. Moreover, a large number of mitotic 
substrates are degraded in mitosis in somatic cells. 
However, Cyclin-Cdk complexes do not regulate the cell cycle on their own. Today more 
cell cycle regulators have emerged that play crucial functions in mitosis and interphase 
and further regulate, boost or repress the activity of Cyclin-Cdk complexes. All of cell 
cycle regulators are highly interconnected by feed-forward and feedback loops that 
make a robust system with a certain level of redundancy13. In particular two recently 
identified kinase families are essential to cell cycle regulation: Polo-like kinases and 
Aurora kinases. Both of them received names from mutant phenotypes in mitosis and 
will be discussed in more detail below. Further, a protein Aurora Borealis has important 
function in the cell cycle. 
 
1.1.2 REGULATION OF THE MITOTIC ENTRY 
Whereas timely Cyclin/protein degradation is important for cell cycle exit and for 
switching between cell cycle phases, regulated Cyclin/protein production is important 
for entry into distinctive phases. The Cyclin B-Cdk complex was identified in Xenopus 
eggs as a factor that drives G2 cells to mitosis (Mitosis Promoting Factor)14. 
Mechanistically, rapid accumulation of cyclins triggers Cdk activation and mitotic 
entry15. Similarly, in somatic cells mitotic entry from G2 is induced by a rapid increase 
in Cyclin B/Cdk1 activity16. However, to control mitotic entry, a crucial balance between 
activation and inhibition of Cdk has to be reached. 
The Cdk1-Cyclin B complex is inhibitory phosphorylated by Wee1 and Myt1 kinases on 
T14 and Y15 residues and is re-activated through dephosphorylation by Cdc25 
phosphatases13. Interestingly, Cdk1 activity itself can regulate these feedback loops; 
active Cyclin B-Cdk1 complexes can phosphorylate Wee1 and Myt1 to inactivate them, 
and can activate Cdc25 phosphatases to further boost its own activity (Figure 2)13. Once 
triggered, this mechanism creates a self-amplifying loop of Cdk activity that leads to 
mitosis. Moreover, there is another level of Cdk activity regulation; Polo-like kinase 1 
(Plk1) is involved in feedback loops contributing to Cdk1 activation by targeting Wee1 
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and Myt1 for degradation and by activating Cdk-activating Cdc25C phosphatase17,18,19. 
Further, Aurora A kinase promotes recruitment of Cdk1 to centrosomes in late G2 and 
phosphorylates Cdk-activating Cdc25B20. 
Interestingly, Plk1 can further boost Cdk1 
and Plk1 activity by directly activating 
FoxM1, a transcription factor that 
regulates multiple genes in mitotic entry 
among others Cyclin B, Cdc25 
phosphatases and Plk121. 
Thus, accumulation of Cdk1 activity is 
supported by multiple redundant feedback 
loops to ensure a robust mechanism for 
mitotic entry. 
Rapid increase in Cyclin B/Cdk1 activity 
occurs shortly before mitosis, however 
low levels of Cyclin B/Cdk1 activity can already be detected in early G216,22. Therefore, 
mitotic entry activation is most likely a gradual process. Mechanistically, it is possible 
that S-phase activities, e.g. DNA replication and S phase Cyclins actively repress Cdk1 
activity and delay accumulation of Cyclin B. Theoretically, in human cells this 
mechanism would allow a sufficient time for repair of replication-induced DNA damage 
and therefore would prevent mitotic errors caused by untimely mitotic entry. 
 
1.1.3 POLO-LIKE KINASE FAMILY: STRUCTURE AND FUNCTIONS 
Human Polo-like kinase 1 was first characterized by Erich Niggs group in 199423. Plk1 
exhibited homology to the previously described polo from Drosophila melanogaster24,25 
and Cdc5 in Saccharomyces cerevisiae26,27. In Drosophila lack of polo produced mutants 
with defective spindle orientation24. Similarly, in S. cerevisiae CDC5 mutants showed 
mitotic spindle anomalies. Golsteyn and colleagues have noticed that Plk1 levels 
fluctuate in a cell cycle dependent manner similarly to Cyclin A and are highest in 
mitosis; moreover Plk1 levels are high in tissues with dividing cells23. Ever since Plk1 
has been recognized as a kinase important in cell division for timely mitotic entry, 
mitosis and cytokinesis28. However, our understanding of Plk1 functions in interphase 
is still limited. Since 2004 Plk1 has emerged as a kinase that is indispensable for mitotic 
entry after DNA damage in G229. And in 2011 Plk1 was suggested to have functions in 
regulation of S phase under stress30. These findings challenge a long-standing view of 
Plk1 as exclusively mitotic kinase. 
Plk1 belongs to the family of serine-threonine kinases that includes four other members 
Plk2, Plk3, Plk4 and latest discovered Plk531.  A special feature of these kinases is the 
presence of two polo box regions that form a polo box domain (PBD) with exception of 
Plk4, that has only one polo box32,33 and Plk5 that lacks kinase domain34. Plk1 consists 
of a N-terminal kinase domain and a C-terminal PBD (Figure3). PBD is an important 
Figure 2. Activation and inhibition of Cyclin-
Cdk1 complex 
  5 
regulatory domain that mediates Plk1 localization to different substrates and allows 
Plk1 to perform its function in the cell cycle19,32. Despite structural similarity between 
polo-like kinase family members, they all have mostly non-redundant functions in cell 
cycle and differentiation31,35. 
The polo box domain of Plk1 is a functional domain that binds phosphorylated peptides. 
The sites recognized by PBD are those phosphorylated by Cdk1 and Plk1 itself19,32. 
Hence through prime-phosphorylation of substrates Cdk1 is involved in spatio-
temporal regulation of Plk1 activity.  Interestingly, the polo-box domain of Plk1 in a 
basal state is thought to inhibit the kinase domain leaving the kinase in an inactive 
conformation (Figure 4). Upon phosphorylation in the T-loop, the PBD is dissociated 
from the kinase domain bringing the kinase into an open active conformation19. 
Therefore, activation of Plk1 is essential to allow Plk1 recruitment to different sub-
cellular localizations to phosphorylate distinct substrates. It is worth a notice that Plk1 
does not interact through its PDB with all substrates. In particular, association with the 
mitotic spindle can occur through direct protein interaction with Map20536. 
Plk1 is recruited in a timely manner to different substrates within the cell (Figure 5). In 
S phase Plk1 is localized to centrosomes37 and is involved in centriole duplication37,38. In 
G2 Plk1 is detected on kinetochores, centrosomes and in cytoplasm in late G222. Plk1 is 
recruited to kinetochores by pre-phosphorylating centromeric protein PBIP1 and 
regulates kinetochore function until anaphase39. Plk1 is involved in centrosome 
maturation and is recruited to pericentrin together with Aurora A, g-tubulin and 
CEP19240; as well as centrosome separation mediated by Eg5 in accordance with 
Cdk141–43; and microtubule nucleation by phosphorylating Nlp44. Further, Plk1 is 
involved in feedback loops boosting Cdk1 activity to promote mitotic entry13.  
Plk1 has prominent functions in mitosis that led to its discovery in the first place. In 
mitosis Plk1 is localized to kinetochores, mitotic spindle, and mitotic poles. As the cell 
approaches cytokinesis Plk1 is localized to the mid-body.  
Figure 3. Structure of Polo-like kinase 1. 
Figure 4. Interaction between a kinase domain and a polo box domain of Plk1. 
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After early recruitment Plk1 targets PBIP1 for degradation39 and further remains on 
kinetochores through interactions with Bub1, Bubr1 and INCENP to regulate 
kinetochore-microtubule attachments45–47. Further Plk1 is involved in activation of the 
anaphase-promoting complex/cyclosome by phosphorylating its inhibitor Emi1 and 
targeting it for SCF-bTrCP-dependent degradation48. Plk1 has functions in positioning of 
the mitotic spindle by controlling switching of dynein/dynactin and phosphorylation of 
LGN/NuMa proteins49. For regulation of cytokinesis and abscission Plk1 translocate to 
the spindle midzone through interaction with PRC150.  
First substrate phosphorylation by Plk1 can be recorded as early as 5 hours before 
mitosis, at the completion of S-phase22,51. Plk1 is activated in G2 through 
phosphorylation of its T-loop on threonine 210 (T210)51,52. This action is performed by 
the mitotic kinase Aurora A in complex with a co-factor scaffolding protein Bora51,53. 
Mechanistically it is thought that Bora binds to the PBD of Plk1 and provides a platform 
for the interaction between Plk1 and Aurora A53. In the absence of Bora, Plk1 T210 is 
phosphorylated by Aurora A very inefficiently, but addition of Bora greatly enhanced 
the activity of Aurora A towards Plk151,53. Cdk1 is found to phosphorylate Bora to 
promote its binding to Plk1 through PBD and facilitate Aurora A–dependent activation 
of Plk154,55. Therefore, Cdk1 activity is underlying Plk1 activation. It is unclear whether 
Cdk1 in complex with Cyclin B is responsible for pre-phosphorylation leading to Plk1 
activation, as new evidence emerges showing that Cyclin A-Cdk1 complex could be 
involved in it 56,57. 
1.1.4 AURORA BOREALIS (BORA) 
Aurora Borealis or Bora was first identified in D. melanogaster as a binding partner and 
activator of Aurora A58. Aurora A mutants similarly to polo mutants exhibited 
centrosome maturation effects and asymmetric spindles. Overexpression of Bora 
rescued these phenotypes to some extend58. Bora levels fluctuate throughout the cell 
Figure 5. A schematic of Polo-like kinase 1 localization during the cell cycle. 
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cycle: low at G1/S border, increase in S phase, peak in G2 and then drop in mitosis. 
Structurally Bora is a protein that does not possess any known regulatory domains58. 
Bora is regulated through post-translational modifications by among others Cdk1, 
Aurora A and Plk153,58–60 and recently three new functional Cdk1 sites on Bora were 
discovered54. 
Bora is essential for Plk1 activation in G2, however once Plk1 is activated it 
phosphorylates Bora and targets it for b-TrCP dependent proteasomal 
degradation55,60,61. Interestingly, experiments with overexpressed Bora in human cells 
show that Bora needs to be downregulated in mitosis, as overexpression leads to 
significant mitotic delay55,60. Since Plk1 degrades its activator at the entry in mitosis it 
has long remained unclear what kept Plk1 active. One possibility was suggested that 
TP2AX, a different co-factor of Aurora A could be involved. Recently we and others have 
shown that a small pool of Bora remains present in mitosis and continues to activate 
Plk160,61. Bora presence in mitosis is in agreement with a requirement for its function, 
since Bora depletion also leads to metaphase arrest due to presence of unaligned 
chromosomes55. Thus, Bora functions in mitosis to regulate Plk1 and Aurora A kinases. 
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1.2 DNA DAMAGE RESPONSE 
We are surrounded by endogenous and exogenous factors that can and do inflict 
damage to our DNA on everyday basis.  Reactive oxygen species, replicative errors along 
with UV-radiation, tobacco, IR-radiation just to name a few62,63. However most of the 
damage occurring on a cellular level goes by unnoticed for an organism as a whole for 
many years. The reason for this is that organisms, both eukaryotic and prokaryotic, 
possess mechanisms that detect and process DNA damage and constantly repair it. 
However, DNA damage although a threat is also a part of a healthy functioning 
organism, as it is a crucial part of the immune response (e.g. lymphocyte maturation and 
antibody production) and meiotic recombination63. The importance of DNA damage and 
repair pathways is highlighted when some of the components don’t work. Patients 
carrying mutations in the essential proteins in these pathways have higher sensitivity to 
DNA- damaging agents and higher incidence of cancer63–65.   
DNA damage response (DDR) is a collective term that describe sensing, processing and 
eventual repair of the DNA damage lesion. Dependent on the type of the lesion there are 
differences in processing and a choice of repair mechanisms. However, the overall DNA 
damage response pathway is thought to look the same: a signal is sensed by a sensor, 
transduced by a transducer and appropriate measures are put in place by effectors65,66.  
To sense the DNA damage different sensors are recruited to different lesions. By 
homology to S. pombe and S. cerevisiae Rad1, Rad9, Hus1, Rad17 are involved in sensor 
complexes in human cells65. Double strand breaks (DSB) are sensed by Mre11-Rad50-
Nbs1 (MRN) complex that further activates and rapidly recruits a transducer to the sites 
of damage. Whereas the border of single and double stranded DNA (ssDNA/dsDNA) at 
breaks can be sensed by Rad17-RFC2-5 clamp loader that further recruits a Rad9-Rad1-
Hus1 complex. Further, the RPA protein that coats ssDNA can also act as a sensor and 
recruit transducer to the site of DNA damage or to a stalled replication fork66. 
Key signaling transducers in mammalian cells are protein kinases ATM (ataxia-
telangiectasia mutated), ATR (ataxia telangiectasia and Rad3-related protein) and DNA-
PK (DNA-dependent protein kinase catalytic subunit)62. ATM and DNA-PK are activated 
and recruited to double-strand breaks (DSBs) after e.g. exposure to genotoxic agents. 
ATR is activated and recruited to RPA-coated single-stranded DNA, which can occur at 
stalled replication forks or as a result of processing of DSBs62. ATM and ATR kinases 
upon activation phosphorylate hundreds of substrates and facilitate rapid signal 
transduction either direct to the effectors or through the downstream signaling 
pathways62,63. One of the best-studied downstream targets of ATM and ATR are Chk2 
and Chk1 kinases. ATM activates Chk2 through direct phosphorylation. Similarly, ATR 
phosphorylates Chk1, stimulated by the adaptor protein Claspin67. Activation of these 
kinases aims to decrease the activity of the cyclin-dependent kinases (Cdks) and other 
mitotic kinases of the cell cycle and impose a checkpoint63,68.  
Checkpoint activation is thought to give a cell time to repair DNA damage69. In parallel 
ATM-, DNA-PK- and ATR-mediated chromatin remodeling of histone H2AX at Ser139 
(gH2AX) at and around the site of damage promotes DNA repair and further signal 
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amplification62,70. Once activated, a cell cycle checkpoint can be sustained by ATM, ATR, 
and Chk2-mediated phosphorylation of the transcription factor p53. P53 
transcriptionally regulates the CDK inhibitor p21 and proapoptotic proteins e.g. BAX 
and Puma and can therefore induce cell cycle arrest, senescence or cell death62,71. DDR 
is a very rigid and robust response, at the same time as it is a dynamic process; since not 
only DNA damage signaling can modify cell cycle proteins, but cell cycle proteins can 
modify the DNA damage signaling. 
 
1.2.1 REPAIR OF DSBs 
DSBs are considered one of the most toxic DNA lesions as they can cause large 
chromosome re-arrangements and require immediate attention72. DSBs can be repaired 
by four different mechanisms: homologous recombination (HR), non-homologous end 
joining (NHEJ), alternative-NHEJ (alt-NHEJ), and single-strand annealing (SSA)72. 
Dependent on the cell cycle stage and DNA end processing requirement different 
mechanisms can be employed. The most common repair mechanisms are HR and NHEJ. 
NHEJ is an error-prone but effective mechanism that can be employed in any stage of 
the cell cycle, with preference towards G1 and M phases. At the same time HR is a more 
complex repair mechanism, but less error prone. It is limited to S and G2 phases of the 
cell cycle, as it requires a homologous chromosome. 
 
1.2.2 CHECKPOINT CONTROL: CELL CYCLE CHECKPOINTS 
Cells respond to DNA damage by activating cell cycle checkpoints69,73. This mechanism 
allows cells to halt the cell cycle progression, evaluate damage and eventually repair it 
or initiate cell death. Checkpoints are important to avoid propagation of lethal 
mutations and avoid genome instability, which is a hallmark of cancer74. Moreover 
checkpoint control is often compromised in a series of hereditary diseases, which 
further underlines the importance of cell cycle control75–77. Dependent on when DNA 
damage was inflicted during the cell cycle, cells pull different types of breaks. Therefore, 
we distinguish G1/S checkpoint, intra-S checkpoint, G2/M checkpoint and M checkpoint 
(spindle assembly checkpoint) (Figure 6). 
Although the DDR response to the DNA damage is in essence the same, the checkpoint is 
established differently in different cell cycle phases. As different protein complexes and 
activities drive distinct stages of the cell cycle78.   
 10 
When DNA damage occurs in G2, cells need to inhibit quickly rising levels of Cyclin-Cdk 
activities, in particular Cyclin B-Cdk1, to prevent mitotic entry79,80. The immediate 
checkpoint break targets feedback loops that keep Cdk1 activity: Cdc25 phosphatases 
are inactivated while Wee1 kinase is activated81,82. At the same time Plk1 and its 
activator Aurora A are inhibited83,84. Further, the immediate checkpoint is sustained by 
slower transcriptional regulation through activation and stabilization of p5371. P53 
promotes transcription and accumulation of p21, which binds Cyclin/Cdk complexes 
and continues cell cycle arrest85,86. Furthermore, although ATM/Chk2 signaling is 
essential in establishing a G2 response, ATR/Chk1 signaling is an essential contributor 
to maintain a G2 arrest. Since it is involved in degradation of Plk1, Bora, Cyclin B, 
Cdc25A for the sake of repair or cell cycle exit81,87–89. 
1.2.3 CHECKPOINT RECOVERY COMPETENCE 
Once DDR has been established and a cell has repaired the damage it can continue the 
cell cycle. However, in order to resume the cell cycle a cell needs to maintain a certain 
level of Cdk activity (Figure 7)90. Failure to keep the Cdk activity leads to inability to re-
enter the cell cycle after the damage was repaired and checkpoint silenced90. At the 
same time, failure to establish a checkpoint and repress Cdk activity after damage leads 
to mitotic entry with unrepaired DNA, a so-called checkpoint adaptation or checkpoint 
override91. Therefore, to keep the checkpoint recovery competence, an ability to 
continue the cell cycle after arrest, a cell needs to maintain a low level expression of G2-
specific genes90. This is achieved by juggling the transcriptional repression and 
continuous expression of the mitotic entry proteins. 
Figure 6. Cell cycle checkpoints: G1/S, S, G2/M and M (spindle assembly checkpoint). 
  11 
A way to keep this tricky balance is provided by the intrinsic nature of the DNA-damage 
response. It is not linear or switch-like, but instead is non-linear and provides pulses of 
DNA damage activity92–94. The tumor suppressor p53 that is a main transcriptional 
repressor in G2 is in the heart of these pulses. P53 pulses are sustained through a 
feedback mechanism, by cycles of Mdm2 activation and de-activation regulated by p53 
itself92. Further, wild-type p53 induced phosphatase 1 (Wip1) regulates the pulses by 
timely dephosphorylation of p53 targets and de-phosphorylation of p53 at S15. Wip1 
depletion results in stable transcriptional repression of the cell cycle regulators Cyclin B 
and Plk1, which leads to G2 arrest and inability to recover after the checkpoint 
silencing95. Moreover, ATM, an upstream regulator of p53 has been shown to display 
oscillations in the activity93,94. 
The pulses of p53 activity after DSBs are suggested to be a mechanism that determines 
cells fate after damage. In particular, cells that exhibit pulses are more likely to enter 
mitosis after arrest than those that don’t96. However, how these pulses are 
mechanistically coupled to the cell cycle regulators is not explicitly shown. One prospect 
is that they provide a possibility for a checkpoint-arrested cell to continue transcription 
of G2-specific proteins to maintain G2-identitity97. 
To continue transcription of pro-mitotic genes as Cyclin B and Plk1 a cell relies on the 
transcription factors FoxM1 and B-Myb90,98. In a feedback manner, Cdk and Plk1 activity 
promote expression of FoxM1 and B-Myb to further boost their own activity21,99,100. 
Therefore, functions of FoxM1 and B-Myb are essential to maintain checkpoint recovery 
competence. 
However, as mentioned earlier regulation of protein expression is only one part of the 
DDR. Equally important is regulation of protein degradation after DNA damage. Upon 
DNA damage APC/C is prematurely activated and targets several proteins including 
Plk1, Cyclin B and Cyclin A for degradation87,101,102. To perform its function after DNA 
damage APC/C depends on its co-activator Cdh1. 
Figure 7. Cell cycle outcomes after checkpoint activation.  
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Degradation of Plk1 by APC/C-Cdh1 is essential to maintain an efficient G2/M 
checkpoint, suggesting that Plk1 degradation in G2 can be associated with loss of 
checkpoint recovery competence87. However, induction of APC/C-Cdh1 does not 
happen immediately after damage, but rather in the later stage of a DDR and marks cell 
cycle exit. In G2, extended p21 induction leads to either irreversible cell cycle exit 
several hours past damage (through nuclear Cyclin B degradation by APC/C-Cdh1) or 
reversible G2 arrest (without Cyclin B degradation and APC/C-Cdh1 activation)86,103. 
Therefore, APC/C activation in G2 marks loss of recovery competence. 
 
1.2.4 APC/C-Cdh1 ACTIVATION UPON DNA DAMAGE 
In a normal cell cycle expression and degradation of proteins in a timely manner 
guarantees unidirectionality of the cycle. Activity of Cyclin-dependent kinases inhibits 
APC/C and vice versa APC/C inhibits Cdk activity by degrading Cyclins104. Additionally, 
Emi1, an inhibitor of APC/C that is expressed from late G1 to mitosis, is essential for 
regulation of APC/C activity. Emi1 allows for accumulation of S phase-specific proteins 
and initiation of S phase. In normal conditions APC/C Cdh1 is inactivated upon entry 
into S phase and becomes active during mitotic exit. In the event of DNA damage there 
are several pre-requisites for ACP/C Cdh1 activation. The DNA damage response, in 
particular p53 activity preconditions APC/C activation by a) enforcing decrease in Cdk 
activity102 b) down-regulating APC/C inhibitor Emi1102. Next, phosphatases involved in 
mitotic exit become active at DNA damage. In particular, Cdc14 phosphatase is released 
from the nucleolus to nucleoplasm and removes inhibitory phosphorylation on Cdh1 
leading to APC/C activation87. 
1.2.5 PLK1 ACTIVATION AFTER DNA DAMAGE 
Similarly as in an unperturbed condition, Plk1 is activated by phosphorylation on T210 
by Aurora A kinase in a complex with Bora to promote G2/M checkpoint recovery51. 
Cdk1 activity is the pre-requisite for this activation by enabling Aurora A/Bora complex 
formation through pre-phosphorylation of Bora54,59. In unperturbed mitotic entry Plk1 
activity is redundant and cells are able to enter mitosis in the absence of Plk1 activity. 
However, upon DNA damage in G2 Plk1-depleted or Plk1-inhibited cells are unable to 
enter mitosis51,105. 
1.2.6 PLK1 AS A TARGET OF DNA DAMAGE SIGNALING 
Upon DNA damage Plk1 is inhibited by several mechanisms. As discussed earlier APC/C 
Cdh1 is activated upon DNA damage in G2 and degrades Plk187. However, early upon 
checkpoint activation Plk1 is not degraded, but its further activation by phosphorylation 
at T210 is prevented. This is achieved by inhibition of Aurora A phosphorylation on 
Plk1/Bora106. Further mechanism of Plk1 inhibition upon DNA damage is SCF-bTrCP 
dependent-degradation of Bora by ATR upon UV-damage88. 
DNA damage signaling inhibits Plk1 to prevent untimely mitotic entry.  In response, 
Plk1 inhibits DNA damage signaling to keep the checkpoint recovery competence and 
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promote the recovery. In relation to cell cycle DNA damage response is established 
throughout several independent axes. First, is immediate activation of Wee1 kinase to 
inhibit Cdk activity, then ATM-Chk2 axis, ATR-Chk1 and direct p53 axis (Figure 8). 
Wee1 kinase axis: Cdk1 together with Plk1 target Wee1 for SCF-bTrCP dependent 
proteasomal degradation17,107. Interference with this degradation leads to inability to 
silence the checkpoint105. 
ATR-Chk1 axis: Active ATR requires adaptor protein Claspin to efficiently 
phosphorylate Chk1 together with Rad9-Rad1-Hus1 complex108,109. Claspin is a cell-cycle 
regulated protein which levels peak in S and G2 phases. Upon DNA damage Claspin is 
transiently stabilized110. Active Plk1 phosphorylates Claspin and targets it for 
degradation by SCF-bTrCP, preventing full Chk1 activation in response to DNA 
damage110–112. Plk1-dependent Claspin degradation is an important step towards 
checkpoint recovery since expression of non-degradable Claspin inhibits mitotic entry. 
ATM-Chk2 axis: Plk1 further counteracts DDR signaling by inactivating Chk2 and 
preventing further activation of 53BP1113. Plk1 phosphorylation of 53BP1 appears to 
cause its dissociation from chromatin and failure to localize to DNA breaks. Plk1 
phosphorylation of Chk2 occurs in its phospho-binding domain and deactivates the 
kinase113. 
P53 axis: Plk1 phosphorylates GTSE1, an Mdm2-dependent negative regulator of p53, 
and causes its translocation to the nucleus114. In the nucleus GTSE1 binds p53 and 
shuttles it out of the nucleus, thereby inhibiting its function114. Furthermore, Plk1 
destabilizes p53 through phosphorylation of Topors, causing increased ubiquitination 
of p53115. Thus, Plk1 modifies and is modified by DNA damage signaling during DNA 
damage arrest in G2. 
  
Figure 8. A schematic of Plk1 counteracting the DNA damage response signaling. 
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1.3 PLK1 AND CANCER 
Plk1 function in checkpoint recovery after DNA damage would suggest that it has an 
oncogenic potential. However, its position on the chromosome has no recorded 
amplifications and the only gene mutation reported leads to Plk1 instability116. And 
several studies, except for one, have shown that its overexpression does not lead to cell 
transformation117–119. Nevertheless, Plk1 is well exploited by proliferating cancers. Plk1 
overexpression has been reported in tumors of colon120–123, lung124, breast125,126, 
ovary127,128 as well as in leukemia129 and this correlates with poor prognosis. In normal 
conditions Plk1 is expressed only in highly proliferative tissues like testis and bone 
marrow (https://www.proteinatlas.org/ENSG00000166851-PLK1/tissue) suggesting 
that its high levels in various cancer tissues is a sign of proliferation.  
Since Plk1 function can contribute to tumorigenesis, it is likely that high Plk1 levels in 
tumors are not just attributed to high proliferation index, but rather reflects 
deregulation of its activity. Something that supports this idea is that Plk1 in cancer cells 
is already expressed at the G1/S border130. Furthermore AURKA, the gene for Aurora A, 
an activator of Plk1, is found to be amplified in human cancers and is associated with 
poor prognosis131. High levels of Aurora A could be contributing to increased Plk1 
activity in malignancies. On the other hand, Plk1 needs to be actively inhibited by DNA 
damage signaling to halt cell cycle progression. A majority of tumors are compromised 
in the DNA damage response through mutations in key proteins e.g. p53, p21, BRCA1 or 
BRCA2 and through failures in signal transduction132,133. This can in turn lead to 
inability to establish or sustain a checkpoint. 
Plk1 is an attractive anticancer target, especially supported by the fact that it has unique 
functions in DNA damaged cells. Several Plk1 kinase inhibitors, among others BI-2536, 
Volasertib, Rigosertib, and GSK461364 were developed and their anti-cancer potential 
was confirmed in pre-clinical studies130,134. However, as a common theme for small 
molecule kinase inhibitors, most of them performed poorly in clinical studies, with 
exception for Rigosertib130,134. First problem encountered is the lack of specificity, that 
leads to off target effects and toxicity. Another issue is that one inhibitor as a 
monotherapy is rarely enough. Cancer cells quickly adapt and find another way to 
proliferate, relapsing in new, usually more resistant tumors.  
However, Plk1 inhibitors are still attractive for cancer treatment, especially in 
combination with other small molecule inhibitors e.g. Aurora A to achieve synergistic 
effects or with classical cancer therapies like irradiation and chemotherapy130,131,134. To 
battle the kinase specificity issues, new PBD inhibitors are in pre-clinical trials (e.g. 
poloxin and purpurogallin)130. Moreover, Plk1 inhibitors can be used as mitotic poisons 
where resistance to traditional cell cycle toxins like vinca alcaloids has been acquired. 
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1.4 METHODS 
Since establishment of the cell cycle field multiple experiments were performed in a 
variety of organisms to elucidate components and mechanisms. Classical examples of 
the cell cycle model systems are simple eukaryotes like yeast S. cerevisiae, S. pombe, a 
sea urchin A. punctulata, a fly D. melanogaster, eggs from a frog Xenopus laevis and 
immortalized human cell lines1.  
Lower eukaryotes and Drosophila revealed through functional mutagenesis new 
proteins and their functions. Xenopus eggs provided a biochemical test tube, a simple 
yet elegant system for understanding protein interactions1. Main components were 
elucidated, purified, enzymatic interactions were tested and phenotypes verified by 
microscopy. Further, diversity of cell cycle phases in population of human cells brought 
the development of synchronization techniques to elucidate averages of protein 
behaviors. Thus, we have learned a lot about cell cycle components from simple 
organisms and translated these findings to humans where system got more complex 
and single discovered proteins were replaced by families of proteins.  
The study of biochemical reactions in a test tube constitutes a complex but very 
controlled process, however chemical reactions inside of living cells are even more 
complex. Availability of compartments and subcellular structures in combination with a 
multitude of substrates allows for difference in speed, dynamics and location of the 
interaction. Recent work in mammalian cell populations revealed the heterogeneity in 
cell cycle decisions and a need for more nuanced understanding of the cell cycle 
choices135. Thus, starting from averages of the cell populations we emerged to single cell 
approaches. A single cell approach would not be possible without the underlying 
technological advances in microscopy, in flow cytometry, in the field of fluorescence 
proteins and biosensors and in single-cell genomics and proteomics.  
 
1.4.1 FRET-BASED BIOSENSORS 
In this thesis I have broadly employed biosensor technology that with the help of a 
physical phenomenon allows measuring kinase activity directly inside a living cell. 
Biosensors for different kinases have been generated among others for ATM, Aurora B, 
Cdk1 and Plk116,51,136–138. 
The biosensor for Plk1 activity like most other kinase biosensors consists of two 
fluorophores, CFP and YFP, joined by a linker with a consensus sequence for the kinase 
and a phospho-binding domain139. In unphosphorylated state CFP and YFP are in close 
proximity and Förster resonance energy transfer (FRET) occurs between the two 
fluorophores. Upon phosphorylation, the probe changes its conformation, since the 
phospho-binding domain binds to the phosphorylated motif, and CFP and YFP lose close 
proximity making FRET very inefficient. With the help of fluorescence microscopy, the 
difference in FRET efficiency can be measured and quantified. 
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When it comes to the design of the probe there are several important aspects to 
consider. Fluorophores used in the design of the probe need to have overlapping 
spectra for energy transfer to occur, however they should not dimerize as it will 
influence the dynamics of the probe. The binding of the phospho-binding domain to the 
phosphosite should be optimized, so that the probe can be phosphorylated and 
dephosphorylated. Next important part is the consensus sequence itself, a difference in 
timing and strength of the signal can occur dependent on the target that is being 
phosphorylated by the kinase. Moreover, if specificity is important a sequence also 
needs to be unique for the kinase of interest, which sometimes can be difficult to 
achieve. Furthermore, a FRET biosensor is a sensor for both kinase and phosphatase 
activities, therefore phosphatase activity can influence the kinetics of the signal. Finally, 
the three-dimensional structure of the probe should allow a conformational change in 
the probe that should lead to as large as possible difference in FRET-efficiency upon 
phosphorylation. All these aspects need to be taken into consideration when using and 
interpreting results obtained by a FRET probe. 
In the Plk1-FRET probe, originally cloned by M. Lampson, the phospho-binding domain 
FHA2 derives from the S. cerevisiae Rad51 protein. Plk1 is a serine-threonine kinase, 
however the FHA2 domain binds phosphorylated threonine more strongly than 
serine140. The consensus sequence for Plk1 in the probe is present in Myt1, but modified 
so that a threonine replaces a serine as phospho-acceptor and an isoleucine is inserted 
at +3 position to enhance binding to FHA2138. This sequence is unique for Plk1 in G2, 
however in mitosis another kinase, Mps1, can marginally contribute to the 
phosphorylation of the probe, since it has a similar consensus site141. Therefore, a FRET 
signal needs to be carefully interpreted. In spite of their limitations, biosensors are 
powerful tools to study kinase activities in live cells with high spatial and temporal 
resolution. 
 
1.4.2 FLUORESCENCE LIVE CELL IMAGING 
Microscopy is an indispensable tool for cell biology as it allows to study events inside 
living cells. However, in live cell imaging a caution needs to be taken with microscopy 
conditions and exposures139,142. Since cell cycle wiring seems to be different in 
unperturbed and perturbed conditions, it is important to put an effort to minimize 
stress in live cell microscopy. The main sources of stress in live cell imaging are 
environmental factors e.g. temperature, media, CO2 supply and phototoxicity from live 
imaging itself. 
Long light exposures during acquisition can be damaging to cells. Even more so are free 
radicals and reactive compounds generated by fluorophore photobleaching. Moreover, 
prolonged exposure of the fluorophore to the light source causes fluorophore bleaching 
that diminishes the strength of the signal139,142. 
Thus, for an optimal signal-to-noise ratio, light and exposure conditions need to be 
adjusted, so that they would allow to study the process without creating a noticeable 
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stress response. The length of the cell cycle is among others a good indicator of stress 
conditions139. 
When it comes to image analysis, the property of light creates uneven background 
distribution further away from the source of light. Unless a cell is present in the precise 
angle straight under the objective, these differences in light distribution needs to be 
compensated by background subtraction. Furthermore, to get a precise quantification of 
the signal, a background subtraction is necessary to further remove autofluorescence 
signals and improve the signal-to-noise ratio22.  
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1.5 GENERAL DISCUSSION 
1.5.1 PLK1 IMPORTANCE FOR MITOTIC ENTRY 
Plk1 activation is necessary to perform its functions in the cell cycle. One main of these 
functions in G2 is boosting Cdk1 activity to facilitate entry into mitosis. Interestingly, 
however, depletion experiments performed for Plk1 in normal conditions resulted in 
cells entering mitosis, although with a delay29, indicating that Plk1 activity may speed 
up activation of Cdk1.  
However, recent data using a small molecule ATP-competitive inhibitor of Plk1 kinase 
show that acute inhibition of Plk1 with high dose of BI2536 in G2 abrogates mitotic 
entry in a majority of cells57. Further cells rely on regaining of Plk1 activity several 
hours after treatment to enter mitosis, since repeated inhibitor treatments decreased 
the resumption of mitotic entry. These data could indicate that once Plk1 gets engaged 
in feedback loops in G2, its activity cannot be easily replaced, since it takes time to 
rewire the network.   
Furthermore, since RNAi usually does not deplete all the protein, the small amount of 
Plk1 activity could be sufficient for the mitotic entry in unperturbed cell cycle. However, 
siRNA treatment blocks checkpoint recovery in the cells subjected to genotoxic stress 
showing a higher requirement for Plk1 activity after DNA damage than during 
unperturbed growth. 
In accordance with Plk1 functions in mitosis, Plk1-inhbited cells do not complete 
mitosis. Instead they arrest in prometaphase with immature centrosomes and, if going 
through mitosis, display chromosome segregation defects 
 
1.5.2 WHERE IS PLK1 ACTIVATED? 
Although mechanistically and biochemically a model is suggested for Plk1 activation, 
the question remains unsolved where exactly Plk1 is activated. The predominantly 
cytoplasmic localization of Aurora A and Bora makes it apparent to suggest that Plk1 is 
activated in cytoplasm. Using a biochemical approach hBora has been detected only in 
the cytoplasmic fraction. Aurora A is known to localize to centrosomes in interphase as 
does Plk1, providing a place and time for Plk1 activation. However, something that 
doesn’t quite fit with the model is that Plk1 activity is first detected in the nucleus 5-6 
hours before mitosis using Plk1-FRET probe. At this point there is no activity detected 
in the cytoplasm and only after 2-3 hours the probe is also phosphorylated there. 
Since the dynamics of Plk1-FRET probe reflects the balance of phosphorylation and 
dephosphorylation, one possibility arises that the phosphatase activity for this 
particular Plk1 substrate is higher in the cytoplasm and therefore Plk1 activity cannot 
be detected there. 
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Another possibility is that Plk1 is indeed activated in the nucleus and a kinase to 
perform this function in the nucleus is Aurora B143. However, recent evidence supports 
the notion that Aurora B is not involved in Plk1 activation in human cells141. 
Alternatively, a small pool of Aurora A can localize to the nucleus in interphase, and 
overexpressed hBora can be also detected in the nucleus making it plausible that at 
least some level of Plk1 activation could occur there. 
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2 AIMS 
The overall goal of my thesis was to study Polo-like kinase 1 activity in G2 during 
unperturbed mitotic entry and after DNA damage. Plk1 is essential for checkpoint 
recovery and it means its activity lies on the crossroads of the DNA damage response 
and cell cycle regulation. Specifically, the respective studies aimed to: 
• develop conditions for using ratiometric imaging to follow a FRET-based 
biosensor for Plk1 activity over several cell cycles with minimal stress induction. 
• develop a setup to follow human cells on micropatterns to detect temporal 
information from both fixed and live cells. Use this setup to detect when mitotic 
kinases, in particular Plk1, is activated. 
• study how degradation of Bora is coordinated with Plk1 activation in nucleus 
and cytoplasm. 
• follow Plk1 activity during a checkpoint response to study possible involvement 
in cell fate decsisions.  
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3 RESULTS AND DISCUSSION 
3.1 MONITORING KINASE AND PHOSPHATASE ACTIVITIES THROUGH THE CELL 
CYCLE BY RATIOMETRIC FRET (PAPER I) 
In this paper we describe and visually demonstrate a setup that allows to perform 
ratiometric imaging of a Förster Resonance Energy Transfer (FRET)-based biosensor 
throughout the cell cycle. We further show how to validate and quantify acquired FRET 
signals using microscopy software. A FRET sensor for kinase activity consists usually of 
two fluorophores, as CFP and YFP, joined by a linker with a consensus sequence and a 
phospho-binding domain. Upon phosphorylation, CFP and YFP lose close proximity, 
which results in loss of FRET. Due to the design, this kind of probe can be both 
phosphorylated by a kinase and dephosphorylated by a phosphatase, reflecting a 
balance of antagonizing activities. Since the cell cycle is likely to be regulated differently 
in unperturbed conditions and during recovery from stress, a caution needs to be taken 
when following the activity of cell cycle proteins by a FRET-probe over time. When it 
comes to stress in ratiometric imaging it can be caused by several factors. Firstly, the 
expression levels of the FRET-probe can interfere with the cell cycle progression by 
competing with a substrate and titrating away binding sites. Secondly, the exposure 
conditions and the nature of ratiometric imaging, that requires acquisition of two 
images at a time, can cause a stress response. Therefore, filming of a FRET-probe during 
at least one cell cycle and comparing cell cycle timings to the normal growing cells gives 
a good preliminary assessment of stress conditions. In case of deviating cell cycle 
timings, the expression level or exposure conditions need to be adjusted.  
With the help of microscopy, a difference in the efficiency of FRET can be measured by 
exciting a donor fluorophore and measuring emission from the acceptor fluorophore. 
This value is then compared to the excitation and emission ratio of the donor 
fluorophore itself. A FRET ratio is calculated between these two excitations-emissions 
with the help of microscopy software. During analysis, a special caution needs to be 
taken in estimating the background value and clipping value. To achieve desired 
visualization of the ratio, an inverted FRET ratio can be calculated. 
Here we discussed how to monitor a FRET-based probe without noticeably perturbing 
the cell cycle and still retain an acceptable signal-to-noise ratio. However, this may not 
be the issue for the probes that study fast responses and short-lived events, but mostly 
has implication for long-term imaging. In this article we have used a diffusible Plk1-
FRET probe, however in case of targeted biosensors, issues with photo-toxicity can have 
stronger impact. In case of H2B-coupled probes, close proximity to DNA can cause DNA 
damage upon excitation of fluorophores. 
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3.2 ASSESSING KINETICS FROM FIXED CELLS REVEALS ACTIVATION OF THE 
MITOTIC ENTRY NETWORK AT THE S/G2 TRANSITION (PAPER II) 
In this research paper we report a micropatterning method, that allows to extract 
kinetics of G2-proteins from fixed cells. Immunofluorescence is a powerful tool that 
allows to visualize the spatial distribution of cell cycle proteins, however it is limited by 
the lack of temporal resolution. Here we developed a method, that allows to extract 
temporal information from a large number of fixed cells, based on the knowledge of 
protein dynamics in the cell cycle. Assuming a gradual increase of the cell cycle 
components144 and having an estimate of the cell cycle duration, allows to assign 
timings to the cells based on strength of the cell cycle signal. Since precise signal 
quantification is essential for the accuracy of this approach, we have employed a system 
that allows to grow cells individually on fibronectin-coated micropatterns. This 
approach reduces cell-to-cell variation in shape and cell-to-cell contact and allows for 
optimal objective angle in image acquisition, which simplifies background subtraction. 
Using our quantitative immunofluorescence approach we find that early activation of 
the mitotic entry network occurs already at the S/G2 border. We detect Cdk1 target 
phosphorylation and a marker for Cdk1-Cyclin B1 activity as early as 5 hours before 
mitosis. We further verify our approach in live cells, by endogenous tagging and 
following of accumulation and degradation of Cyclin A and Cyclin B along with 
monitoring of Plk1 activity using a biosensor. Tracking of Plk1 activity together with the 
dynamics of PCNA foci reveals activation of Plk1 at the S/G2 border, 5 hours before 
mitosis. Similar to Cdk1 activity, Plk1 activity remained coupled to S-phase even after 
prolonged thymidine treatment. Thus, our results show that contrary to previous 
findings16, the mitotic entry network is activated at the S/G2 border, several hours 
before mitosis. Furthermore, our results indicate that S phase can play an important 
role in the regulation of G2 phase. 
In embryonic cycles G2 phase is mostly absent and mitotic entry can occur shortly after 
DNA replication. This would require a rapid activation of Cyclin-Cdk complexes that 
leads to mitosis. In somatic cells G2 phase is rather long, 5-6 hours, however a rapid 
increase in activation of Cyclin-Cdks is reserved for last 40 min before mitotic entry. 
Artificial extension of S phase leads to a delay in G2-specific target phosphorylation. 
Therefore, a mechanism can exist that allows for S phase to regulate the speed of 
accumulation of mitotic proteins and cyclins, by actively inhibiting them. Since S-phase 
progression in the absence of DNA damage requires ATR activity through Chk1 and its 
regulatory protein Claspin109, a possibility exists that ATR-Claspin-Chk1 could actively 
counteract Plk1 accumulation and activation in S phase. 
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3.3 PHOSPHORYLATION-MEDIATED STABILIZATION OF BORA IN MITOSIS 
COORDINATES PLX1/PLK1 AND CDK1 OSCILLATIONS (PAPER III) 
In this paper we and our collaborators have employed two different approaches in two 
different model organisms, Xenopus egg oocytes and human somatic cells, to study Bora 
degradation. In Xenopus oocytes periodical inactivation of Cdk1 through APC/C-
mediated degradation of Cyclins creates an oscillator. Plk1/Plx1 is an important cell 
cycle regulator that facilitates Cdk1 activation and entry into mitosis. In somatic cells 
Bora/Aurora A activate Plk1, which upon activation targets Bora for proteasomal 
degradation. This activation is coordinated by Cdk1, that initially pre-phosphorylates 
Bora and creates a docking site for Plk1/Aurora A interaction. Plk1 in somatic cells is 
degraded by APC/C-Cdh1 upon completion of mitosis. However, in Xenopus oocytes 
Plx1 levels are stable, but Plx1 activity is regulated by that phosphorylation oscillates. 
How these oscillations of Plx1 activity in early cycles were generated and how Plk1 
activity was sustained during mitosis remained unclear.  
Here we find that in oocytes, degradation of Bora regulates oscillations of Plx1 activity 
between mitosis and interphase. Embryonic Bora degradation, similar to in somatic 
cells, requires phosphorylation of Bora by Cdk1 and Plk1. In arrested oocyte extracts 
Bora is phosphorylated on the T52 consensus site of Cdk1. This phosphorylation 
stabilizes Bora by blocking its degradation. Calcineurin in a calcium-dependent manner 
dephosphorylates the T52 site and Bora can be degraded, thus the calcium surge that 
occurs at fertilization can trigger Plx1 oscillations.  
In somatic cells we have followed the dynamics of degradation of GFP-Bora. We record 
that GFP-Bora degradation slowly starts approximately 2 hours before mitosis when 
Plk1 activity monitored by Plk1-FRET probe begins to build up in the cytoplasm. 
Interestingly, this degradation stops as the cells enter mitosis, and GFP-Bora becomes 
stabilized in mitosis when Cdk1 is fully active. Taken together our results suggest that 
Cdk1 controls Bora degradation and stabilization in an incoherent feed-forward manner 
that coordinates Plk1/Plx1 and Cdk1 activity. 
With regard to Bora degradation and Plk1 activity it is tempting to speculate that 
spatio-temporal coordination of these events is not a coincidence. GFP-Bora localizes 
predominantly to the cytoplasm in human cells, and our results indicate that there is no 
active shuttling to the nucleus. Plk1 activity measured by a diffusible Plk1-FRET probe 
is first detected in the nucleus as early as 5 hours before mitosis, suggesting that this is 
where Plk1 phosphorylates its first substrates. However, the cytoplasmic activity of 
Plk1 becomes apparent later, approximately 2 hours before mitosis. Although it is not 
clear where Plk1 is activated, this spatial resolution could allow to preserve Bora in the 
cytoplasm after Plk1 activation and contribute to a delay for the Plk1-Bora negative 
feedback loop. 
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3.4 CELL CYCLE EXIT AFTER DNA DAMAGE CAN OCCUR AT TWO POSITIONS IN 
G2 PHASE (PAPER IV) 
In this manuscript we followed single RPE cells after infliction of DNA damage to 
checkpoint recovery or cell cycle exit. After DNA damage, activation of the checkpoint 
leads to two different outcomes: cell cycle resumption or cell cycle exit. However, the 
decision depends on the cell cycle stage when damage was inflicted and the amount of 
phase-specific activity. Moreover, a checkpoint is established differently in different cell 
cycle stages. Here we monitored Plk1 activity in live cells by the Plk1-FRET sensor to 
follow cell cycle activities and simultaneously followed a Geminin-RFP probe to monitor 
APC/C-Cdh1 activity. We find that cells damaged in all cell cycle stages can recover or 
exit cell cycle, however they do it with different dynamics. In case of G2, late G2 cells do 
not arrest after damage, but continue into mitosis, whereas early G2 cells exit the cell 
cycle by premature activation of APC/C-Cdh1. Interestingly, there is a point marked by a 
threshold level of Plk1 activity in G2, where a direct decision to enter or exit the cell 
cycle seem to be taken.  
Furthermore, cells damaged in S phase can exit the cell cycle with or without 
upregulation of Plk1 activity. Interestingly, both G2 damaged cells and S damaged cells 
that upregulated Plk1 activity could reach approximately the same threshold of Plk1 
activity. We conclude that cell cycle exit is possible at two positions in G2 and that Plk1 
activity is not required for cell cycle exit after damage in S phase. Moreover, cells 
damaged in G1 phase and overcoming the G1/S checkpoint do not necessary commit to 
mitosis, as we find that they can also exit the cell cycle after S phase in a similar manner 
as cells damaged in S phase.  
Interestingly, our results fit well with the observation that after genotoxic stress cells 
accumulate in G1 and G2 phases of the cell cycle. Moreover, a checkpoint can be 
efficiently established in G1 and G2 phases, but in S phase accumulation of p21 is 
inhibited by replication-coupled degradation78. The same might be true for late G2, 
where high Cdk and Plk1 activity inhibit the checkpoint. The fact that premature 
activation of APC/C-Cdh1 in G2 leads to cell cycle exit has been already reported86,103. 
Cyclin B translocation to the nucleus marks a point of no return for the cell cycle 
progression. P53 induction and p21 accumulation in the nucleus are mechanistical clues 
to cell cycle exit in G2. However, what triggers APC/C-Cdh1 activation after damage is 
unknown. Lowered Cdk1 activity and degradation of the APC/C inhibitor Emi1 could be 
contributing factors104. Plk1 is an established target for APC/C-Cdh1 activity, and 
several hours after DNA damage Plk1 can be degraded. 
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4 FUTURE OUTLOOK 
 
Life is simple and complex at the same time. Although, the life basics can be simple, the 
individual processes can evolve in complexity the more we learn about them. 
The more we learn about cell cycle networks the more complex they become.  Cell cycle 
regulations seems to be intertwined with the majority, if not all, essential processes 
within the cell. Cell cycle is connected to metabolic processes, various stress responses, 
DNA damage response, DNA repair and others. On one hand, some of these connections 
are expected e.g. those of metabolic processes that regulate cell growth145. On the other 
hand, they highlight how much is still there to explore.  
Cell cycle pathways are interlinked thought a plethora of feedback and feedforward 
loops that regulate signal transduction. However, the more we learn about contribution 
of the individual loops to the whole pathway, the less intuitive an understanding of the 
process becomes. Therefore, a mathematical modeling could be a future way to 
approach the rising complexity of the networks. A modelling approach could allow to 
incorporate single processes, characterized by single interaction loops into a model of 
the bigger process and predict behaviors for the whole network. 
Furthermore, advances in microcopy and other screening approaches allow for fast 
accumulation of a big number of data. However, the speed of data processing is limited. 
Thereof there is a need for efficient processing of the large data sets and a better way to 
present them. Computer learning and artificial intelligence could contribute to the 
solution in the future.  
Single cell approaches are essential in understanding of the somatic cell cycle networks. 
Since we are all individuals. However, we are also a system. Rules within a system could 
be different than those for single individuals, moreover, a signal transduction between 
cells may change the way individual cells respond to the stimuli. For example, cells can 
communicate DNA damage through bystander communication and the effects are 
increasingly obvious in cancers146. Therefore, it is important to extend the knowledge 
obtained in singe cells to the tissue or organ. These studies, could be really important in 
the understanding of complex processes like tumorigenesis. 
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